19-47320268-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001736.4(C5AR1):c.491C>A(p.Ala164Asp) variant causes a missense change. The variant allele was found at a frequency of 0.0000514 in 1,613,382 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A164S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001736.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
C5AR1 | NM_001736.4 | c.491C>A | p.Ala164Asp | missense_variant | 2/2 | ENST00000355085.4 | |
C5AR1 | XM_047439300.1 | c.593C>A | p.Ala198Asp | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
C5AR1 | ENST00000355085.4 | c.491C>A | p.Ala164Asp | missense_variant | 2/2 | 1 | NM_001736.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000880 AC: 22AN: 249976Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135240
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1461192Hom.: 0 Cov.: 79 AF XY: 0.0000220 AC XY: 16AN XY: 726920
GnomAD4 genome AF: 0.000276 AC: 42AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2022 | The c.491C>A (p.A164D) alteration is located in exon 2 (coding exon 2) of the C5AR1 gene. This alteration results from a C to A substitution at nucleotide position 491, causing the alanine (A) at amino acid position 164 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at